Mitsubishi Ufj Kokusai Asset Management Co., Ltd. I Mab Put Options Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $122 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IMAB
# of Institutions
38Shares Held
13.8MCall Options Held
20KPut Options Held
13.3K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$21 Million0.15% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$14.6 Million3.04% of portfolio
-
Candriam S.C.A.1.13MShares$3.98 Million0.02% of portfolio
-
Sg Americas Securities, LLC876KShares$3.08 Million0.01% of portfolio
-
Stonepine Capital Management, LLC Bend, OR484KShares$1.7 Million0.39% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $292M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...